Search for Clinical Trial Results

Sponsored By

Limb-girdle Muscular Dystrophy Type 2A - 11 Studies Found

Status Study
Recruiting Study Name: A Trial of PF-06252616 in Ambulatory Participants With LGMD2I
Condition: LGMD2I
Date: 2016-07-12
Interventions: Drug: PF 06252616
Enrolling by invitation Study Name: Gene Transfer Clinical Trial for LGMD2D (Alpha-sarcoglycan Deficiency) Using scAAVrh74.tMCK.hSGCA
Condition: Limb Girdle Muscular Dystrophy Type 2D (LGMD2D)
Date: 2013-07-24
Interventions: Drug: scAAVrh74.tMCK.hSGCA
Completed Study Name: Muscle MRI in Becker Muscular Dystrophy and in Limb-girdle Muscular Dystrophy Type 2I
Condition:
  • Becker Muscular Dystrophy
  • Limb-Girdle Muscular Dystrophy Type 2
    Date: 2014-06-11
Completed Study Name: Clinical Study of AAV1-gamma-sarcoglycan Gene Therapy for Limb Girdle Muscular Dystrophy Type 2C
Condition:
  • Limb Girdle Muscular Dystrophy Type 2C
  • Gamma-sarcoglycanopathy<
    Date: 2011-03-17
    Interventions: Biological: AAV1-gamma-sarcoglycan vector injection single intramuscular injection into carpi radialis m
Completed Study Name: Deflazacort in Dysferlinopathies
Condition:
  • LGMD2B
  • Miyoshi Myopathy
  • Dysfe
    Date: 2007-09-06
    Interventions:
    • Drug: deflazacort In the first
Completed Study Name: Gene Transfer Therapy for Treating Children and Adults With Limb Girdle Muscular Dystrophy Type 2D (LGMD2D)
Condition: Muscular Dystrophies
Date: 2007-06-27
Interventions:
  • Genetic: rAAV1.tMCK.human-alpha-sarcoglycan- First cohort

Completed Study Name: MRI on Persons With Mutations in POMT2 Gene (LGMD2N)
Condition: Limb-girdle Muscular Dystrophy
Date: 2016-04-27
Active, not recruiting Study Name: Clinical Outcome Study for Dysferlinopathy
Condition:
  • Dysferlinopathy
  • LGMD2B
  • Miyosh
    Date: 2012-08-28
Recruiting Study Name: Congenital Muscle Disease Study of Patient and Family Reported Medical Information
Condition:
  • Congenital Muscular Dystrophy (Including Unspecified/Undiagnosed)
  • Dystroglycanopathy
    • Date: 2011-07-26
Completed Study Name: The Safety and Biological Activity of ATYR1940 in Patients With Limb Girdle or Facioscapulohumeral Muscular Dystrophies
Condition:
  • Limb-Girdle Muscular Dystrophies
  • Facioscapulohumeral Muscular Dystrophy

Date: 2015-09-28
Interventions:
  • Biological: ATYR1940 Intrapati
Next >>>